ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Historical Holders from Q4 2017 to Q3 2025

Symbol
KIDS on Nasdaq
CUSIP
68752L100
Type / Class
Equity / Class A common stock, $0.00025 par value
Shares outstanding
25.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
16.5M
Holdings value
$306M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
109
Number of buys
50
Number of sells
-59
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTEGRATED CORE STRATEGIES (US) LLC 5.5% $25.8M 1.39M Millennium Management LLC Oct 29, 2025
BlackRock, Inc. 4.96% $28.4M 1.23M BlackRock, Inc. Jun 30, 2025
BROWN CAPITAL MANAGEMENT LLC 4.31% -34.7% $20M -$10.9M 1.08M -35.3% Brown Capital Management, LLC Sep 30, 2025

Institutional Holders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16.5M $306M -$6.46M $18.53 109
2025 Q2 16.8M $361M +$2.21M $21.48 116
2025 Q1 16.7M $411M +$5.14M $24.63 114
2024 Q4 16.5M $383M +$777K $23.18 107
2024 Q3 16.3M $443M +$1.5M $27.11 122
2024 Q2 16.2M $467M +$11.2M $28.76 121
2024 Q1 15.9M $462M -$12.3M $29.16 117
2023 Q4 24.3K $791K +$579K $32.51 2
2023 Q3 16.2M $519M +$6.47M $32.00 112
2023 Q2 16M $700M -$10.9M $43.85 119
2023 Q1 16.2M $718M +$13.6M $44.29 120
2022 Q4 15.9M $633M -$20.4M $39.73 115
2022 Q3 15.1M $698M +$7.53M $46.14 115
2022 Q2 15.1M $653M +$8.9M $43.15 111
2022 Q1 14.8M $798M +$16.8M $53.99 119
2021 Q4 14.4M $863M -$42.6M $59.86 120
2021 Q3 14.7M $964M -$16.2M $65.51 139
2021 Q2 15M $949M +$34.8M $63.18 134
2021 Q1 14.6M $714M -$10.4M $48.75 121
2020 Q4 14.7M $607M +$28.4M $41.25 126
2020 Q3 13.9M $640M +$41.1M $45.92 119
2020 Q2 13.1M $572M +$88.2M $43.76 127
2020 Q1 10.9M $432M +$57.5M $39.64 101
2019 Q4 9.51M $447M +$84.9M $46.99 104
2019 Q3 7.49M $264M +$9.64M $35.26 85
2019 Q2 7.17M $280M +$1.24M $39.00 97
2019 Q1 7.15M $316M +$23.4M $44.23 93
2018 Q4 6.62M $231M +$50.3M $34.88 74
2018 Q3 5.17M $189M +$5.65M $36.64 60
2018 Q2 5.14M $137M +$19M $26.64 53
2018 Q1 4.51M $68M +$3.72M $15.06 45
2017 Q4 4.16M $79.8M +$79.8M $19.19 48